Enzymes have been identified in animal tissues that catalyze the mono(ADP-ribosyl)ation of arginine and proteins. Since these NAD:arginine ADP-ribosyltransferases under physiological conditions do not appear to catalyze the degradation of the product ADP-ribose-arginine, the possibility was investigated that a different family of enzymes exists that cleaves the ADP-ribose-arginine linkage. An ADP-ribosylation is a covalent modification catalyzed by viral, bacterial, and animal enzymes (1, 2); the ADP-ribose moiety of NAD is transferred to either an acceptor protein or amino acid or to another ADP-ribose moiety to yield an acceptor-linked monomer or polymer (1, 2). These synthetic reactions are catalyzed by two classes of enzymes: (i) mono(ADP-ribose)transferases, which catalyze the mono(ADP-ribosyl)ation of proteins, and (ii) poly(ADPribose) synthetases, which catalyze the initial ADP-ribosylation of protein and subsequent chain elongation (3-6). The importance of the mono(ADP-ribosyl)ation reaction has been best documented for bacterial toxins that exert their effects on cells by modifying critical enzymes (7-13). Choleragen (cholera toxin) and Escherichia coli heat-labile enterotoxin, agents involved in the pathogenesis of cholera and traveler's diarrhea, respectively, modify a stimulatory GTP-binding protein of the adenylate cyclase system, leading to an increase in cellular cyclic AMP (9, 12, 13). Pertussis toxin (islet-activating protein) ADP-ribosylates and inactivates an inhibitory component of adenylate cyclase (10-13). Diphtheria toxin and Pseudomonas exotoxin A modify elongation factor II, thereby inhibiting protein synthesis and causing cell death (7, 8); an ADP-ribosyltransferase endogenous to animal cells is believed to catalyze a reaction similar to diphtheria toxin (14) . Although the metabolic role of poly(ADP-ribose) synthetase has not been defined, it is closely linked to chromatin-associated events (1, 6).
mono(ADP-ribosyl)ation of proteins, and (ii) poly(ADPribose) synthetases, which catalyze the initial ADP-ribosylation of protein and subsequent chain elongation (3) (4) (5) (6) . The importance of the mono(ADP-ribosyl)ation reaction has been best documented for bacterial toxins that exert their effects on cells by modifying critical enzymes (7) (8) (9) (10) (11) (12) (13) . Choleragen (cholera toxin) and Escherichia coli heat-labile enterotoxin, agents involved in the pathogenesis of cholera and traveler's diarrhea, respectively, modify a stimulatory GTP-binding protein of the adenylate cyclase system, leading to an increase in cellular cyclic AMP (9, 12, 13) . Pertussis toxin (islet-activating protein) ADP-ribosylates and inactivates an inhibitory component of adenylate cyclase (10) (11) (12) (13) . Diphtheria toxin and Pseudomonas exotoxin A modify elongation factor II, thereby inhibiting protein synthesis and causing cell death (7, 8) ; an ADP-ribosyltransferase endogenous to animal cells is believed to catalyze a reaction similar to diphtheria toxin (14) . Although the metabolic role of poly(ADP-ribose) synthetase has not been defined, it is closely linked to chromatin-associated events (1, 6) .
Among the ADP-ribosyltransferases endogenous to animal cells are those that catalyze the formation of ADP-ribosearginine (15) (16) (17) (18) (19) . These enzymes, which also modify proteins, presumably using a guanidino moiety as an ADP-ribose acceptor, have been identified and purified from turkey erythrocytes, chicken liver, and rabbit muscle (15) (16) (17) (18) (19) . A family of NAD:arginine ADP-ribosyltransferases has been identified in turkey erythrocytes, where different transferases are localized in the nucleus, cytosol, and membrane fractions (16, 17, 20) . These transferases differ in physical, kinetic, and regulatory properties (20) . The bacterial toxins, choleragen and E. coli heat-labile enterotoxin, also possess NAD:arginine ADP-ribosyltransferase activity (21, 22) ; toxin-catalyzed activation of the adenylate cyclase system is believed to result from modification of an arginine residue on a cyclase regulatory protein (23) .
The mechanism for the reversal ofthe mono(ADP-ribosyl)-ation reaction has not been elucidated fully. The pyrophosphate moiety of protein-bound ADP-ribose is cleaved by a phosphodiesterase activity that is fairly common in animal tissues (24, 25) . In extracts from Simian virus 40-transformed mouse fibroblasts (SVT2), ADP-ribose-protein was degraded by endogenous enzymes to release compounds tentatively identified as ADP-ribose and phosphoribose, although other products were formed consistent with proteolytic digestion to yield an ADP-ribose-(amino acid) peptide conjugate(s) (26) . To study the reversal of ADP-ribosylation, it was decided to examine the degradation of a model compound, ADP-ribosearginine, and thus to circumvent the problems inherent in characterization of the products of a more complex ADPribose-protein degradation. Since turkey erythrocytes were the source of a family of NAD:arginine ADP-ribosyltransferases responsible for the synthetic reaction, this tissue was examined for the presence of ADP-ribose-arginine cleavage enzymes. Protein was determined by a modification of the method of Lowry et al. (28) with bovine serum albumin as a standard or by a dye-binding assay (Bio-Rad).
MATERIALS AND METHODS

Materials
Protein Purification. NAD:arginine ADP-ribosyltransferase A purified from turkey erythrocytes as described (16) exhibited one major protein band on NaDodSO4/polyacrylamide slab gels.
The ADP-ribose-arginine cleavage enzyme was partially purified from the supernatant fraction (27,000 x g, 20 min) of a turkey erythrocyte homogenate by successive chromatography on DE-52 cellulose, phenyl-Sepharose, and organomercurial agarose. This procedure, although it produced only =200-fold purification, did remove a number of contaminating activities, such as pyrophosphatases, that act on the ADP-ribose moiety (25) .
RESULTS
Degradation of ADP-ribose-L-[14C]arginine by the partially purified cleavage enzyme was enhanced by dithiothreitol ( Fig. 1) and MgCl2 ( Figs. 1 and 2 ). Activation was maximal with 5-10 mM dithiothreitol and 5-10 mM MgCl2 (Fig. 2) . (11.5 ,uM; 21,600 cpm) was incubated for 20 min at 30°C without (0) or with (o) organomercurial agarose-purified ADP-ribose-arginine cleavage enzyme (9.65 ,g) as described for assay of its activity. A sample (0.02 ml) was applied to a sheet (0.1 mm) of polyethyleneimine-cellulose MN 300 impregnated with fluorescent indicator. After (Fig. 3 A and B) 7 .0/10 mM MgCI2/5 mM dithiothreitol in the presence or absence of organomercurial agarose-purified cleavage enzyme (0.161 mg) in a total vol of 1 ml for 3 hr. The solution was then applied to a phenylboronate column (1.5-ml bed vol). The sample volume (1 ml) and 4 ml of a 5 mM potassium phosphate, pH 8.0/10mM MgCl2 wash were collected (total vol, 5 ml). Two 0.1-ml aliquots were applied to an amino acid analyzer (Beckman 6300) to determine the effect of cleavage enzyme on generation of [14C] arginine. The recovery of [14C]arginine in the 5-ml eluate was 39.3%. exhibited a mobility similar to that of ADP-ribose by thinlayer chromatography (Fig. 4) .
These studies tentatively identified the products of ADP-
ribose-L-[14C]arginine degradation by the cleavage enzyme as
ADP-ribose and L-[14C]arginine. To confirm further the identity of the cleavage enzyme product as arginine and to demonstrate that the guanidino moiety was preserved during the cleavage reaction (i.e., excluding ornithine and citrulline as possible products), the radiolabeled product formed during degradation of ADP-ribose-L-[14C]arginine by the cleavage enzyme was resolved by chromatography on a phenylboronate resin and identified as arginine by amino acid analysis (Table 1 ). This radiolabeled compound was incubated with excess NAD and the purified erythrocyte NAD:arginine ADP-ribosyltransferase; the radiolabeled product of the transferase-catalyzed reaction adhered to the phenylboronate resin and had a mobility identical to that of ADP-ribose-L-[14C]arginine by thin-layer chromatography (Table 2 and data not shown). Formation of the presumed ADP-ribose-L-
[14C]arginine conjugate was dependent on NAD and ADPribosyltransferase (Table 2) . Addition ofunlabeled arginine in excess of the NAD inhibited the incorporation of radiolabel into ADP-ribose-L-[14C]arginine (Table 2) .
DISCUSSION
The present report documents the presence of an ADPribose-L-arginine cleavage enzyme in turkey erythrocytes. The enzyme appears to catalyze the degradation of ADPribose-L-arginine to ADP-ribose and arginine in a reaction that is stimulated by Mg2' and dithiothreitol. The purification procedure separated this activity from other enzymes that act on the substrate, such as phosphodiesterases (25) . In animal tissues, enzymes have been identified that transfer ADP-ribose to at least two different amino acids in acceptor proteins, glutamate and arginine (15) (16) (17) (18) (19) (29) (30) (31) (32) .
The glutamate residues of histones are modified by poly(ADP-ribose) synthetase, an enzyme that catalyzes both the initial ADP-ribosylation of protein as well as the subsequent chain elongation and branching to yield a poly(ADPribosyl)ated protein (1, (3) (4) (5) (6) The presumed product of the cleavage reaction, [14C]arginine, was generated from ADP-ribose-[14C]arginine by action of the organomercurial affinity column-purified cleavage enzyme, as described in the legend to Table 1 . To convert the putative [14C]arginine to its ADP-ribosylated derivative, the radiolabeled compound (10,400 cpm; 66.6 ,uM) was incubated with the indicated additions in 25 mM Hepes (pH 8.0) with ovalbumin (1 mg/ml) and 100 mM NaCl in a total vol of 0.2 ml; NAD:arginine ADP-ribosyltransferase, 1 milliunit; 1 mM NAD; additional arginine, 10 mM. After 2 hr at 30°C, 0.02-ml aliquots were applied to a boronate affinity column. Unadsorbed cpm (pH 8 "run-through" and wash) and adsorbed cpm eluted with 50 mM sodium acetate (pH 5.0) are termed in the proceed through phosphodiesterases (24, 25) , working on the pyrophosphate linkage to yield phosphoribosyl-AMP and poly(ADP-ribose) glycohydrolases (33) (34) (35) , which act on the ribose-ribose linkages to yield ADP-ribose. Hayaishi The chemical techniques used to identify the products might not differentiate between compounds having minor differences in structure with ADP-ribose and arginine. Action of a specific rat liver lyase on the ADP-ribose-histone, which was formed by degradation of poly(ADP-ribose)-protein, results in the synthesis of an elimination product distinct from ADP-ribose (37) . It is clearly difficult to determine whether the glutamate residue of the histone is altered; from a mechanistic viewpoint, elimination of the ADP-ribose should proceed with regeneration intact of the glutamate moiety. Degradation of ADP-ribose-arginine by the cleavage enzyme appears to generate an arginine moiety; by using the model substrate in place of a protein acceptor, it was possible to characterize more fully the amino acid product. The compound appears to be arginine, based on identification and quantification by amino acid analysis and its mobility on thin-layer chromatograms. Furthermore, this compound formed by cleavage enzyme degradation of ADP-ribosearginine served as a substrate for the NAD:arginine ADPribosyltransferase; in a reaction dependent on NAD and transferase, a compound was generated having the characteristics of ADP-ribose-arginine. Thus, it would appear that the presence of both transferase and cleavage enzyme may lead to an ADP-ribosylation/de-ADP-ribosylation cycle, lending further support to the hypothesis that this covalent modification may have a regulatory function in animal cells. Identification of the natural substrates for these enzymes will be necessary to define the physiological role of argininespecific ADP-ribosylation.
